Halliburton Company

(New York Stock Exchange)
Bullish +75

Cramer's lightning round: 'I like Halliburton very much'

πŸ“’ Jim Cramer hosts his weekly "Mad Money" lightning round to answer rapid-fire stock questions from viewers.

⚠️ He advises against buying Beam Therapeutics unless investors believe their technology can save lives, noting the stock is heavily shorted with no earnings.

❌ Cramer suggests skipping Ondas due to heavy losses and a lack of distinctiveness in its autonomous systems compared to competitors.

πŸ›’οΈ Halliburton receives strong praise as he describes it as a great stock that performs well in both good and bad oil markets, calling it very inexpensive.

πŸ“‰ Snap is rejected by Cramer because he identifies primarily as a growth buyer and finds the company lacks necessary growth trajectory.

πŸ† Nokia is named a winner by Cramer, who applauds the company for returning with strong technology despite past struggles.

β›½ Cameco Corporation is recommended as a "real" uranium company that stands out from mock companies lacking genuine resources.

πŸ’‰ Novo Nordisk receives a negative outlook from Cramer, who suggests investors in that sector would be better off buying Johnson & Johnson instead.

🏍️ Harley-Davidson is criticized by Cramer for having terrific technology but terrible earnings, leading him to refuse recommending the non-growth stock.

Bullish Signals
  • Jim Cramer states he likes Halliburton very much, highlighting its ability to perform well in both good and bad oil markets.
  • According to Cramer, Halliburton continues to be considered a very inexpensive stock despite its strong market performance.
Risk Factors
  • Halliburton stock has been described as 'awful' in terms of performance compared to growth-focused peers.
  • The article notes that Halliburton is a target of heavy short interest, which often correlates with poor market sentiment and lack of earnings support.
Full Analysis
During a "Mad Money" lightning round, host Jim Cramer offered rapid-fire investment opinions on several companies following their year-to-date stock performance. He expressed strong bullish sentiment toward Halliburton, stating he likes the stock very much because it has performed well in both good and bad oil markets and remains inexpensive. In contrast, Cramer advised against buying Snap, describing it as a growth investor with no growth, which explains its poor recent performance. For Nokia, he called it a "winner" that has finally returned and possesses good technology after sticking around through tough times. Cramer's comments on other companies were mixed or bearish. He declined to recommend Beam Therapeutics unless an investor is certain the company can save lives, warning against buying heavily shorted stocks without earnings. He criticized Ondas as a money-losing company in the autonomous systems sector with nothing distinct about its business model. For Cameco Corporation, he praised it as a real uranium company and a "winner," distinguishing it from mock alternatives. Conversely, he suggested Novo Nordisk was not good at what it does compared to competitor J&J for that specific industry. Finally, regarding Harley-Davidson, Cramer acknowledged the technology is terrific but criticized the earnings as "blah," refusing to recommend non-growth stocks on his show. The segment concluded with a push for CNBC's Investing Club and resources for investors.